FloBio LLC

Developing a novel point-of-care precision diagnostic platform for the rapid assessment of bleeding & clotting risk in emergency, trauma critical care settings.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded August 2017
  • Employees 5
  • Incorporation Type LLC
  • Website flobiollc.com

Company Summary

FloBio is pioneering a game changing point-of-care diagnostic that assesses blood clotting function in emergency critical care patients. Rapid analysis of flowing blood has the potential to precisely identify the presence & source of clotting problems. Early risk identification and personalized management within the critical decision making window can lead to fewer patient complications, improved clinical outcomes, and reduced healthcare costs.

Team

  • Jerri Ann, a full time FloBio CEO since July 2018, received degrees from The Wharton School & Washington University. With over 25 years of executive-level business leadership experience, she brings an exceptional track record & breadth & depth of experience across the product development & commercialization spectrum. With a passion for new product planning & building businesses, she has been instrumental in shaping company vision & operations.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free